Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

ICER says Pfizer's Paxlovid, Merck's molnupiravir both cost effective, but their benefits are far from equal
Fierce Pharma
Tue, 05/10/22 - 10:50 am
Tags:
ICER, Pfizer, Paxlovid, Merck, Ridgeback Biotherapeutics, molnupiravir, COVID-19
BioNTech's Q1 vaccine sales triple but it still flags full-year decline
Yahoo/Reuters
Mon, 05/9/22 - 10:35 am
Tags:
BioNTech, earnings, vaccines, Pfizer, COVID-19
COVID vaccine makers shift focus to boosters
Yahoo/Reuters
Mon, 05/9/22 - 10:13 am
Tags:
COVID-19, vaccines, boosters, Pfizer, Moderna Therapeutics
In wake of Biogen's skirmish with the SEC, pharma giants are changing the way they do quarterly reports
Endpoints
Thu, 05/5/22 - 11:34 pm
Tags:
Biogen, earnings, SEC, Eli Lilly, Merck, Bristol Myers Squibb, Pfizer, AbbVie
Pfizer Is Poised to Shatter These 2 Records in 2022
Motley Fool
Thu, 05/5/22 - 10:41 am
Tags:
Pfizer, earnings, Paxlovid
FDA rebukes Pfizer CEO’s suggestion to take more Paxlovid if COVID-19 symptoms return
Fierce Pharma
Wed, 05/4/22 - 05:46 pm
Tags:
Pfizer, Albert Bourla, Pharma CEOs, FDA, Paxlovid, COVID-19
Another Pfizer gene therapy is free of FDA hold, but delay continues
Fierce Biotech
Tue, 05/3/22 - 10:53 pm
Tags:
Pfizer, FDA, clinical trials, hemophilia A, gene therapy, giroctocogene fitelparvovec, Sangamo Therapeutics
Exclusive: Connect Biopharma reports a PhII fail for Zeposia challenger, and execs appear ready to punt
Endpoints
Tue, 05/3/22 - 10:46 pm
Tags:
Connect Biopharma, Pfizer, Bristol Myers Squibb, FDA, clinical trials, ulcerative colitis, CBP-307
Pfizer cuts 2022 earnings outlook despite strong first-quarter Covid vaccine and antiviral sales
CNBC
Tue, 05/3/22 - 10:34 pm
Tags:
Pfizer, earnings, COVID-19, vaccines, Paxlovid
Paxlovid's post-exposure protection flop hardly spells the end for Pfizer's COVID franchise: analysts
Fierce Pharma
Mon, 05/2/22 - 11:54 am
Tags:
Pfizer, Paxlovid, COVID-19, antivirals, clinical trials
Pfizer loses top vaccine scientist Jansen who led drive for COVID-19 shot, searches for successor
Fierce Pharma
Sat, 04/30/22 - 02:38 pm
Tags:
Pfizer, vaccines, Kathrin Jansen, COVID-19
FDA to discuss Pfizer, Moderna requests for COVID vaccines in young kids in June
Yahoo/Reuters
Fri, 04/29/22 - 10:19 am
Tags:
FDA, vaccines, COVID-19, Pfizer, BioNTech, Moderna Therapeutics
FDA clears Pfizer to restart Duchenne gene therapy trial, with new safeguards
BioPharma Dive
Thu, 04/28/22 - 10:56 am
Tags:
Pfizer, gene therapy, Duchenne Muscular Dystrophy, clinical trial, FDA
How Paxlovid came to be: From the germ of an idea to a vital tool against Covid
Stat
Thu, 04/28/22 - 10:47 am
Tags:
Paxlovid, Pfizer, antivirals, COVID-19
Biohaven migraine drug partnered with Pfizer lands twin European approvals
MedCity News
Wed, 04/27/22 - 10:38 pm
Tags:
Europe, Pfizer, Biohaven, migraines, rimegepant
Spying synthetic lethal promise, Pfizer bets $25M on Zentalis, will support cancer trials
Fierce Biotech
Wed, 04/27/22 - 10:49 am
Tags:
Pfizer, Zentalis Pharmaceuticals, synthetic lethality
Pfizer asks FDA to authorize booster shots for kids ages 5 through 11
NPR
Tue, 04/26/22 - 10:21 pm
Tags:
Pfizer, FDA, boosters, vaccines, pediatric, COVID-19
Did Johnson & Johnson's CFO Just Spell Trouble for Moderna and Pfizer?
Motley Fool
Tue, 04/26/22 - 10:37 am
Tags:
JNJ, Pfizer, Moderna Therapeutics, vaccines, COVID-19, earnings, pandemic
Valneva and Pfizer report positive Phase 2 data for Lyme disease vaccine in children
Biopharma Reporter
Tue, 04/26/22 - 10:27 am
Tags:
Valneva, Pfizer, clinical trials, vaccines, VLA15, Lyme disease, pediatric
Biden administration starts Covid treatment push, focusing on Pfizer’s Paxlovid
Stat
Tue, 04/26/22 - 10:07 am
Tags:
Joe Biden, antivirals, Paxlovid, Pfizer, COVID-19

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.